Benefits, harms and cost-effectiveness of cervical screening, triage and treatment strategies for women in the general population
Open Access
- 12 December 2023
- journal article
- research article
- Published by Springer Nature in Nature Medicine
- Vol. 29 (12) , 3050-3058
Abstract
In 2020, the World Health Organization (WHO) launched a strategy to eliminate cervical cancer as a public health problem. To support the strategy, the WHO published updated cervical screening guidelines in 2021. To inform this update, we used an established modeling platform, Policy1-Cervix, to evaluate the impact of seven primary screening scenarios across 78 low- and lower-middle-income countries (LMICs) for the general population of women. Assuming 70% coverage, we found that primary human papillomavirus (HPV) screening approaches were the most effective and cost-effective, reducing cervical cancer age-standardized mortality rates by 63–67% when offered every 5 years. Strategies involving triaging women before treatment (with 16/18 genotyping, cytology, visual inspection with acetic acid (VIA) or colposcopy) had close-to-similar effectiveness to HPV screening without triage and fewer pre-cancer treatments. Screening with VIA or cytology every 3 years was less effective and less cost-effective than HPV screening every 5 years. Furthermore, VIA generated more than double the number of pre-cancer treatments compared to HPV. In conclusion, primary HPV screening is the most effective, cost-effective and efficient cervical screening option in LMICs. These findings have directly informed WHO’s updated cervical screening guidelines for the general population of women, which recommend primary HPV screening in a screen-and-treat or screen-triage-and-treat approach, starting from age 30 years with screening every 5 years or 10 years.Keywords
All Related Versions
Funding Information
- World Health Organization
This publication has 66 references indexed in Scilit:
- Screening patterns within organized programs and survival of Italian women with invasive cervical cancerPreventive Medicine, 2013
- Early human papillomavirus testing predicts residual/recurrent disease after LEEPJournal of Gynecologic Oncology, 2012
- LEEP Verses Cryotherapy in CINThe Journal of Obstetrics and Gynecology of India, 2011
- Evaluation of primary HPV-DNA testing in relation to visual inspection methods for cervical cancer screening in rural China: an epidemiologic and cost-effectiveness modelling studyBMC Cancer, 2011
- Prevention of cervical cancer in rural China: Evaluation of HPV vaccination and primary HPV screening strategiesVaccine, 2011
- HPV Screening for Cervical Cancer in Rural IndiaNew England Journal of Medicine, 2009
- The predicted impact of vaccination on human papillomavirus infections in AustraliaInternational Journal of Cancer, 2008
- Cervical intraepithelial neoplasia outcomes after large loop excision with clear margins2000
- The Use of Large Loop Excision of the Transformation Zone (LLETZ) in an Outpatient SettingAustralian and New Zealand Journal of Obstetrics and Gynaecology, 1996
- Efficacy and safety of large-loop excision of the transformation zoneThe Lancet, 1994